Skip to main content

Advertisement

SpringerLink
Log in

New Paradigms in Understanding Chronic Pelvic Pain Syndrome

  • Published:
Current Urology Reports Aims and scope Submit manuscript

Abstract

Chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) is a common male pain condition that is associated with significant discomfort and disability. Despite significant efforts, there remains no definitive etiology or treatment of the spectrum of pelvic symptoms reported by these patients. The purpose of this review is to summarize important clinical and scientific findings related to CP/CPPS from the previous 2 years, and to evaluate their impact on our understanding of, and approach to, the disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Mehik A et al. Epidemiology of prostatitis in Finnish men: a population-based cross-sectional study. BJU Int. 2000;86(4):443–8.

    Article  PubMed  CAS  Google Scholar 

  2. Collins M et al. Prevalence and correlates of prostatitis in the health professionals follow-up study cohort. J Urol. 2002;167(3):1363–6.

    Article  PubMed  Google Scholar 

  3. Diseases, N.I.o.D.a.D.a.K. Executive summary: NIH workshop on chronic prostatitis. 1995. Bethesda, Maryland.

  4. Nickel JC et al. Prevalence of prostatitis-like symptoms in a population based study using the national institutes of health chronic prostatitis symptom index. J Urol. 2001;165(3):842–5.

    Article  PubMed  CAS  Google Scholar 

  5. Ferris JA et al. National prevalence of urogenital pain and prostatitis-like symptoms in Australian men using the National Institutes of Health Chronic Prostatitis Symptoms Index. BJU Int. 2010;105(3):373–9.

    Article  PubMed  Google Scholar 

  6. Liang C-Z et al. The prevalence of prostatitis-like symptoms in China. J Urol. 2009;182(2):558–63.

    Article  PubMed  Google Scholar 

  7. Tripp DA et al. Prevalence, symptom impact and predictors of chronic prostatitis-like symptoms in Canadian males aged 16–19 years. BJU Int. 2009;103(8):1080–4.

    Article  PubMed  Google Scholar 

  8. Mendall MA, Goggin PM, Molineaux N, Levy J, Tossy T, Strachan D, et al. Relation on H. Pylori infection and coronary artery disease. Br Heart J. 1994;71:437–9.

    Article  PubMed  CAS  Google Scholar 

  9. Rebora A, Drago F, Piccioto A. Helicobacter pylori infection in patients with rosacea. Am J Gastroenterol. 1994;71:437–9.

    Google Scholar 

  10. Kanbay M, Gur G, Akcay A, Yilmaz U. Helicobacter pylori seroprevalence in patients with chronic bronchitis. Respir Med. 2005;99:1213–6.

    Article  PubMed  Google Scholar 

  11. Karatas OF et al. Helicobacter pylori seroprevalence in patients with chronic prostatitis: a pilot study. Scand J Urol Nephrol. 2010;44(2):91–4.

    Article  PubMed  CAS  Google Scholar 

  12. Rudick CN et al. Uropathogenic Escherichia coli induces chronic pelvic pain. Infect Immun. 2011;79(2):628–35.

    Article  PubMed  CAS  Google Scholar 

  13. Nickel JC et al. Examination of the relationship between symptoms of prostatitis and histological inflammation: baseline data from the REDUCE chemoprevention trial. J Urol. 2007;178(3):896–901.

    Article  PubMed  Google Scholar 

  14. Nickel JC et al. Leukocytes and bacteria in men with chronic prostatitis/chronic pelvic pain syndrome compared to asymptomatic controls. J Urol. 2003;170(3):818–22.

    Article  PubMed  Google Scholar 

  15. Schaeffer AJ et al. Leukocyte and bacterial counts do not correlate with severity of symptoms in men with chronic prostatitis: the national institutes of health chronic prostatitis cohort study. J Urol. 2002;168(3):1048–53.

    Article  PubMed  Google Scholar 

  16. True LD, Berger RE, Rothman I. Prostate histopathology and the chronic prostatitis/chronic pelvic pain syndrome: a prospective biopsy study. J Urol. 1999;162.

  17. Thumbikat P et al. Prostate secretions from men with chronic pelvic pain syndrome inhibit proinflammatory mediators. J Urol. 2010;184(4):1536–42.

    Article  PubMed  Google Scholar 

  18. Watanabe T, et al. Nerve growth factor level in the prostatic fluid of patients with chronic prostatitis/chronic pelvic pain syndrome is correlated with symptom severity and response to treatment. BJU Int. 2010;p. Epub ahead of print.

  19. Davis SNP, et al. Tenderness as measured by pressure pain thresholds extends beyond the pelvis in chronic pelvic pain syndrome in men. The Journal of Sexual Medicine. 2010;p. Epub ahead of print.

  20. Clemens JQ et al. Validation of a modified National Institutes of Health chronic prostatitis symptom index to assess genitourinary pain in both men and women. Urology. 2009;74(5):983–7.e3.

    Article  PubMed  Google Scholar 

  21. Shoskes DA et al. Clinical phenotyping of patients with chronic prostatitis/chronic pelvic pain syndrome and correlation with symptom severity. Urology. 2009;73(3):538–42.

    Article  PubMed  Google Scholar 

  22. Hedelin HH. Evaluation of a modification of the UPOINT clinical phenotype system for the chronic pelvic pain syndrome. Scand J Urol Nephrol. 2009;43(5):373–6.

    Article  PubMed  Google Scholar 

  23. Magri V et al. Use of the UPOINT chronic prostatitis/chronic pelvic pain syndrome classification in European patient cohorts: sexual function domain improves correlations. J Urol. 2010;184(6):2339–45.

    Article  PubMed  Google Scholar 

  24. •• Shoskes DA, Nickel JC, Kattan MW. Phenotypically directed multimodal therapy for chronic prostatitis/chronic pelvic pain syndrome: a prospective study using UPOINT. Urology. 2010;75(6):1249–1253. According to the authors, treatment of CP/CPPS symptoms by phenotypic classification has shown promise.

    Article  PubMed  Google Scholar 

  25. Tugcu V, Tasci AL, Fazlioglu A, Gurbuz G, Ozbek E, Sahin S, et al. A placebo-controlled comparison of the efficiency of triple- and monotherapy in category IIIB chronic pelvic apin syndrome (CPPS). Eur Urol. 2006;51(4):1113–8.

    Article  PubMed  Google Scholar 

  26. Nickel JC et al. Alfuzosin and symptoms of chronic prostatitis—chronic pelvic pain syndrome. N Engl J Med. 2008;359(25):2663–73.

    Article  PubMed  CAS  Google Scholar 

  27. Nickel JC, Narayan P, McKay J, Doyle C. Treatment of chronic prostatitis/chronic pelvic pain syndrome with tamsulosin: a randomized double blind trial. J Urol. 2004;171(4):1594–7.

    Article  PubMed  CAS  Google Scholar 

  28. • Chen Y, et al. Effects of a 6-month course of tamsulosin for chronic prostatitis/chronic pelvic pain syndrome: a multicenter, randomized trial. World J Urol. 2010; 1–5. According to the authors, 6-month treatment with tamsulosin is no more effective than placebo for CP/CPPS symptoms.

  29. Rosenstock J et al. Pregabalin for the treatment of painful diabetic peripheral neuropathy: a double-blind, placebo-controlled trial. Pain. 2004;110(3):628–38.

    Article  PubMed  CAS  Google Scholar 

  30. Dworkin RH et al. Pregabalin for the treatment of postherpetic neuralgia. Neurology. 2003;60(8):1274–83.

    PubMed  CAS  Google Scholar 

  31. Crofford LJ, Rowbotham MC, Mease PJ, et al. Pregabalin for the treatment of fibromyalgia syndrome: results of a randomized, double-blind, placebo-controlled trial. Arthritis Rheum. 2005;52(4):1264–73.

    Article  PubMed  CAS  Google Scholar 

  32. • Pontari MA, et al. Pregabalin for the treatment of men with chronic prostatitis/chronic pelvic pain syndrome: a randomized controlled trial. Arch Intern Med. 2010;170(17):1586–1593. According to the authors, pregabalin treatment is no more effective than placebo for CP/CPPS symptoms.

    Article  PubMed  CAS  Google Scholar 

  33. FitzGerald MP et al. Randomized multicenter feasibility trial of myofascial physical therapy for the treatment of urological chronic pelvic pain syndromes. J Urol. 2009;182(2):570–80.

    Article  PubMed  Google Scholar 

  34. Gottsch HP, Yang CC, Berger RE. A pilot study of botulinum toxin A for male chronic pelvic pain syndrome. Scand. J. Urol. Nephrol. 45(1):72–6.

  35. Kabay S et al. Efficiency of posterior tibial nerve stimulation in category IIIB chronic prostatitis/chronic pelvic pain: a sham-controlled comparative study. Urol Int. 2009;83(1):33–8.

    Article  PubMed  Google Scholar 

  36. Vandoninck V et al. Posterior tibial nerve stimulation in the treatment of urge incontinence. Neurourol Urodyn. 2003;22(1):17–23.

    Article  PubMed  Google Scholar 

  37. Vandoninck V et al. Percutaneous tibial nerve stimulation in the treatment of overactive bladder: urodynamic data. Neurourol Urodyn. 2003;22(3):227–32.

    Article  PubMed  Google Scholar 

  38. Zimmermann R et al. Extracorporeal shock wave therapy for the treatment of chronic pelvic pain syndrome in males: a randomised, double-blind. Placebo-controlled study. Eur Urol. 2009;56(3):418–24.

    Article  PubMed  Google Scholar 

  39. Tugcu V et al. Effectiveness of acupuncture in patients with category IIIB chronic pelvic pain syndrome: a report of 97 patients. Pain Med. 2010;11(4):518–23.

    Article  PubMed  Google Scholar 

  40. Koo VSW, O’Brien A. Local anesthetic and steroidal prostatic injection for chronic pelvic pain syndrome: an effective last resort? Clin J Pain. 9000. Publish Ahead of Print: p. 10.1097/AJP.0b013e3181f89971.

  41. Sönmez N, et al. Sexual dysfunction in type III chronic prostatitis (CP) and chronic pelvic pain syndrome (CPPS) observed in Turkish patients. Int Urol Nephrol. 2010;1–6.

  42. Clemens JQ, Brown SO, Calhoun EA. Mental health diagnoses in patients with interstitial cystitis/painful bladder syndrome and chronic prostatitis/chronic pelvic pain syndrome: a case/control study. J Urol. 2008;180(4):1378–82.

    Article  PubMed  Google Scholar 

  43. Rodríguez MÁB, Afari N, Buchwald DS. Evidence for overlap between urological and nonurological unexplained clinical conditions. J Urol. 2009;182(5):2123–31.

    Article  PubMed  Google Scholar 

  44. Zhao F-L et al. Health-related quality of life in Chinese patients with chronic prostatitis/chronic pelvic pain syndrome. Qual Life Res. 2010;19(9):1273–83.

    Article  PubMed  Google Scholar 

  45. Clemens JQ, Markossian T, Calhoun EA. Comparison of economic impact of chronic prostatitis/chronic pelvic pain syndrome and interstitial cystitis/painful bladder syndrome. Urology. 2009;73(4):743–6.

    Article  PubMed  Google Scholar 

Download references

Disclosures

No potential conflicts of interest relevant to this article were reported.

Author information

Authors and Affiliations

  1. Department of Urology, University of Michigan Medical Center, 1500 East Medical Center Drive, 3875Taubman Center, Ann Arbor, MI, 48109–5330, USA

    Katy S. Konkle & J. Quentin Clemens

Authors
  1. Katy S. Konkle
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. Quentin Clemens
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to J. Quentin Clemens.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Konkle, K.S., Clemens, J.Q. New Paradigms in Understanding Chronic Pelvic Pain Syndrome. Curr Urol Rep 12, 278–283 (2011). https://doi.org/10.1007/s11934-011-0185-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11934-011-0185-1

Keywords

Search

Navigation